Could a Hole in My Heart Be Behind My Retinal Artery Occlusion?
Retinal Artery Occlusion and a Hole in the Heart at a Glance
Sudden vision loss in one eye is an emergency. Call 911 or go to the emergency room right away. Do not wait to see if it clears. Eye specialists advise that a fresh artery blockage in the eye be handled like a brain stroke, with care in the first hours1.
- Sudden vision loss in one eye, with no pain
- A dark curtain or shadow across part of your sight
- Sight that went out, then came back
- New face droop, arm weakness, or slurred speech
- Sudden double vision
Here is the calming part. This trip is not only about the eye. Doctors use those hours to find the clot source and to cut your odds of a brain stroke. Stroke risk is highest in the first one to four weeks, and it fell in the range of 3 to 6 of every 100 people in two studies1. Finding the cause is what makes prevention possible.
Yes, a small flap between the top chambers of the heart can send a clot to the eye, though it is not the usual cause. A national heart statement lists paradoxical emboli, meaning clots that cross from the vein side to the artery side, among the less common causes worth screening for in selected patients2. The flap is called a patent foramen ovale, or PFO. It matters most when you are young and the usual culprits come back clean.
A retinal artery occlusion is a blocked artery inside the eye. The retina is the light-sensing film at the back of the eye, and it needs steady blood flow. Because retinal tissue dies from lack of blood the way brain tissue does, this event counts as a form of acute ischemic stroke and gets the same prevention plan used after a brain stroke2.
What a Patent Foramen Ovale Is, in Plain Words
Before birth, blood skipped your lungs by crossing a doorway between the two upper heart chambers, called the foramen ovale. It usually seals in the first months of life. In many people it never seals fully, and a thin flap stays loose enough to open under pressure. That leftover flap is a PFO. It works more like a trap door pushed ajar when you strain than a gap in the heart wall.
Common enough that finding one is rarely a shock. In an autopsy study of 965 normal hearts, a patent foramen ovale was present in about 27 of every 1003. A neurology practice advisory puts it at roughly 1 of every 4 adults4. If one in four adults has a PFO, finding one in you does not by itself explain your eye.
A small clot from a leg vein normally drifts to the lungs, where fine vessels trap it. A PFO offers a detour. If pressure on the right side of the heart rises, the flap can open and let blood cross to the left side, skipping the lung filter. From there it goes straight out to the body, including the artery feeding your retina. Doctors call that detour a paradoxical embolism2.
What Actually Causes a Retinal Artery Occlusion
The usual suspect is the carotid artery in your neck. Cholesterol plaque builds up there, a fleck breaks loose, and it lodges in the retinal artery. In one European workup study, 31 of 77 patients had narrowing of more than 70 percent in that artery, and a single center series found critical carotid disease in about 37 of every 100 patients2. That is why a scan of your neck comes before any heart hunting.
The heart sends clots too. An irregular rhythm called atrial fibrillation lets blood pool and clot in a heart pocket. Worn valves shed debris. In that European workup study, about 20 of every 100 patients had a rhythm problem and about 17 of every 100 had valve disease, and longer rhythm monitoring finds atrial fibrillation more often after this kind of eye event2. A PFO is different: the clot does not form in the heart, the heart just lets it pass.
Think of the PFO as a route, not a source. It sits low on the list for a patient in their seventies with high blood pressure and neck-artery plaque. It climbs when the patient is young, the arteries are clean, and the rhythm monitor is quiet. The published record is small: one review gathered seven reported cases of central retinal artery occlusion with a PFO, at an average age near 42 years5. Seven cases is a hint, not a body of evidence.
Not every blocked retinal artery comes from a traveling clot. Giant cell arteritis, a swelling of medium and large arteries in older adults, can close the vessel from within. Guidelines advise suspecting it in patients over 50 and note that about 20 of every 100 affected people lose vision without usual warning signs such as headache or jaw pain1. Clotting disorders and cosmetic facial filler shots are other known routes, each with its own test.
Age, sex, and family history are fixed. Most of the rest is not. Smoking, high blood pressure, body weight, high blood lipids, diabetes, clotting disorders, and heart disease including atrial fibrillation are all listed as changeable risk factors tied to retinal emboli1. Work on those and you protect your other eye, your brain, and your heart.
How a Retinal Artery Occlusion Shows Up
The classic story is abrupt and silent. Sudden painless vision loss is the most common symptom, taking all of the sight in one eye when the central artery is blocked and part of it when a branch is blocked6. There is no redness, ache, or discharge. The lack of pain is why people wait, which is worth knowing in advance.
A branch blockage takes a slice, not the whole picture. You might lose the top half, the bottom half, or a wedge to one side. Reading vision can survive if the blocked branch fed elsewhere. A branch occlusion still calls for the same body-wide search for the clot source as a central one1. Milder vision loss does not mean a milder cause.
Vision that blacks out for seconds and then returns has a name, amaurosis fugax. Silent brain infarcts show up often in patients with these brief episodes or with an artery blockage, and they carry a high risk of future stroke, so prompt referral to a stroke center is advised1. If your sight came back on its own, you still need the workup. Its return is not the all clear.
The Eye Exam and the Heart Workup After an Eye Stroke
A dilated look at the back of the eye settles the diagnosis. The retina turns pale where it lost blood, and the center shows a cherry red spot because the layer beneath still has flow. A dilated exam or a fundus photograph is needed to confirm it and to rule out other causes of sudden painless vision loss, such as a detached retina, bleeding inside the eye, or optic nerve disease2.
The advised sequence pairs an immediate eye exam with a nerve exam, blood tests that include platelet count, sedimentation rate, C-reactive protein, and clotting studies, plus a scan of the brain and neck vessels2. Brain imaging is not a formality. Up to about 24 of every 100 patients with a retinal artery occlusion have a concurrent brain infarct on diffusion weighted magnetic resonance imaging1.
The heart is checked in layers, easiest first. An electrocardiogram catches a rhythm problem present that minute, and a wearable monitor catches the on-and-off kind. An echocardiogram through the chest wall is a reasonable next step, given how often heart structure problems turn up in these patients, and some period of wearable rhythm monitoring is right when no other cause is clear2.
Finding a PFO takes a specific look. In a bubble study, frothed saline is put into an arm vein while the heart is filmed. Bubbles on the left side mean blood is crossing over. If doubt remains, a transesophageal echocardiogram passes a probe into the swallowing tube under sedation. In the review of seven reported cases, the chest wall study showed the flap in 1 of the 7, while the swallowed probe was needed in the other 65.
Under about 50, the list widens. Guidance calls for a body-wide stroke evaluation at any age, with a giant cell arteritis workup over 50 and a search for rarer causes under 50, such as vessel swelling or clotting disorders, including antiphospholipid antibodies when no clot source is found1. Neck artery tears after trauma belong there too, and this is the stage where a PFO check usually enters the talk.
Deciding Whether the PFO Is the Culprit or a Bystander
A PFO is common in healthy people, so its presence in you is weak evidence on its own. The neurology advisory counsels telling patients that a PFO is found in roughly 1 of every 4 adults and that pinning down its causal role in any one stroke stays hard4. Your team is not dodging when they call the PFO possibly incidental.
Some features shift the odds. Young age, no high blood pressure or diabetes, no smoking, clean neck arteries, and a normal rhythm monitor all make an innocent PFO less likely to be the whole story. A leg vein clot or an event that began during heavy straining adds weight. In the pooled trials, the gain from closure sat with patients who had a large shunt or a floppy septum rather than those without7.
Neurologists have a scoring tool for this call. The Risk of Paradoxical Embolism index, built from pooled data across 12 databases, scores how likely it is that a PFO found after an unexplained stroke is the cause rather than a chance finding, with the highest scores in younger patients who have no vascular risk factors8. It was built for brain strokes, so using it for an eye event stretches its evidence. Ask what your score suggested.
The rest of your workup changes what the same echo report means.
| What your workup shows | What a PFO finding likely means |
|---|---|
| Age over 60, neck artery plaque, or atrial fibrillation found | More likely a chance finding; the known cause drives treatment |
| Young age, clean arteries, normal rhythm, nothing else found | More likely relevant; worth a full cardiology talk |
| Large shunt or a floppy septum, meaning a bulging wall between the upper chambers (clinical: atrial septal aneurysm), plus a vein clot or recent strain | Strongest case for a clot crossing the flap |
Treatment and Prevention After the Occlusion
This part is hard news, told straight. After the sudden phase, no treatment is established to restore the vision lost to these blockages, and current evidence is not enough to support clot dissolving drugs for central occlusion1. Across 8 studies of 396 untreated patients, 70 regained useful vision, and older bedside steps such as eye massage did not beat that2. Clot dissolving drugs given early are still under study.
The care that earns its place aims at your next event, not your last one. Treating high blood pressure, lipid disorders, diabetes, obesity, and sleep apnea, plus quitting smoking and staying active, follows set stroke prevention guidelines, and an antiplatelet plan like the one used after an unexplained brain stroke is reasonable when there is no cause for a stronger blood thinner or surgery2.
Closure is a catheter procedure. A device is threaded up a leg vein and opened across the flap, and tissue grows over it later. The neurology advisory frames closure as a talk for patients under 60 who had an embolic looking stroke with no other mechanism found after a thorough workup, and advises against routine closure when a higher risk mechanism is identified4. Whether an eye event qualifies is a call your neurologist and cardiologist make together.
The numbers are real but modest, and they carry a trade. Closure cut the five year absolute risk of another stroke by about 3 of every 100 people versus medical therapy alone4. Pooling 6 randomized trials in 3,560 patients, closure lowered repeat stroke versus blood-thinning medicine, major procedure complications hit about 2 of every 100 closures, and new atrial fibrillation was several times more common after closure7. Those are group averages from brain stroke trials, not a promise about your eye.
Risks, Recovery, and the Realistic Outlook
Expect limited recovery in the injured eye, though this says nothing about the other one. Fewer than 20 of every 100 patients regain useful sharpness in the affected eye, and in one series of 121 patients followed over time, close to 80 of every 100 stayed at count fingers vision or worse2. When a spare vessel called a cilioretinal artery happens to be present, central vision can stay near normal.
The window right around the event is the risky one, and the one you can act on. In a US cohort of 300 patients, 16 had a symptomatic ischemic stroke around the time of the occlusion, and stroke was more frequent when the blockage was embolic9. That is one cohort at one health system, so read it as a rough shape, not a forecast. Finish the workup on time, and start prevention without gaps.
Months later, the starved retina can sprout fragile new vessels that raise pressure inside the eye and can bring on a painful glaucoma. These patients need eye follow-up to watch for new vessel growth, and laser treatment with or without injections is advised if new vessels appear on the retina, iris, or drainage angle1. Keep your appointments even if nothing feels different, since this one stays quiet early.
Depth judgment takes a hit, and so does the field of view on that side. Most people adapt over weeks by turning the head more and leaving extra room when driving. Guidance includes providing or referring for vision rehabilitation services when a patient has vision loss from this disease1. Ask about low vision help early rather than a year on.
When to Call Your Doctor and Who to See
Some symptoms belong in an emergency room, not a clinic. Go for sudden vision loss in either eye, a curtain or shadow across your sight, new double vision, or the brain stroke signs of face droop, arm weakness, and speech trouble. An acute occlusion with symptoms warrants immediate referral to the nearest stroke center for prompt assessment1. Do not drive yourself. Call 911 so care starts on the way.
After the emergency phase, this becomes a shared problem. Long term prevention works best as a partnership between a neurologist, an eye doctor, and a primary care doctor, with the eye doctor tracking remaining vision and the neurologist pinning down the cause and setting prevention2. Add a cardiologist if a PFO or a rhythm problem is on the table. If nobody is coordinating, ask your primary care doctor to lead.
Questions Patients Ask About PFO and Eye Stroke
Not by itself. A PFO is found in roughly 1 of every 4 adults4, so most people who have one never have an eye or brain event. Your team weighs your age, your neck arteries, your heart rhythm, and whether anything else explains the blockage. If the rest of the workup is clean and you are younger, the PFO becomes a more believable route. If plaque or an irregular rhythm turned up, that finding usually takes priority.
Probably not as a first step. In an older adult with vascular risk factors, the neck arteries and the heart rhythm are the likelier sources, and those tests come first2. A bubble study is usually saved for people whose workup comes back with no explanation, or when clues point to a clot crossing from the vein side. Ask your neurologist whether the result would change your treatment; if not, the testing adds cost and worry.
No. Closure aims at stopping a future event, not at repairing retina that is already hurt. After the sudden phase, no treatment is established to restore the vision these blockages take1. That is hard to hear, and it is better heard clearly than softened. The value of any prevention step, closure included, lies in guarding your other eye and your brain.
Longer than a single office tracing, though the best length has not been settled. Longer monitoring finds atrial fibrillation more often after this kind of event2, so many teams use a patch or event recorder for days to weeks. Some people with an otherwise unexplained event go on to longer monitoring still. One normal reading in the emergency department does not rule out an on-and-off rhythm problem.
It is uncomfortable rather than painful, and it is done under sedation. A flexible probe is guided into your swallowing tube so the ultrasound sits just behind the heart. That gives a clearer view of the wall between the upper chambers than imaging through the chest5. You will skip food beforehand and need a ride home. Ask what question the study is meant to answer before agreeing to it.
It is a known pattern, though never proof on its own. A clot crossing from the vein side to the artery side is a recognized, less common cause worth screening for in selected patients2. Long stillness raises the chance of a leg vein clot, and straining raises pressure on the right side of the heart, which can push the flap open. If you had a recent long trip, surgery, cast, or a hard strain right before your vision changed, say so. That history changes how hard your team hunts for a clot.
More Questions About Testing, Closure, and Recovery
That happens, and it is not a dead end. An unexplained event is still treated, usually with antiplatelet medicine and firm control of blood pressure, lipids, and blood sugar, the approach used after an unexplained brain stroke2. Your team may extend rhythm monitoring or add a PFO check at that point. Ask what would reopen the search later, and keep copies of your results.
Not directly, and that is worth naming. The randomized trials of PFO closure enrolled people with cryptogenic brain stroke7, not retinal artery occlusions, so applying them to an eye event stretches the evidence. The biology is shared, since both are blockages in arteries fed by the same circulation, but the trial data are not eye specific. That gap is a reason for a full talk about benefits and harms.
They are real and belong in the decision. In the pooled randomized trials, major procedure complications hit about 2 of every 100 closures, and new atrial fibrillation was several times more common in the closure groups7, and that rhythm problem can itself need treatment. Against those harms sits a modest drop in future stroke over five years. Whether the trade is worth it depends on how likely the flap was the route for you.
Take this list to your next visit and write the answers down.
- What did my neck artery imaging and heart rhythm monitoring show?
- Has a cause been identified, or is my event still unexplained?
- Am I a candidate for a bubble study, and what would the result change?
- If a PFO is found, who decides whether it is relevant?
- How often should my eyes be checked for new vessel growth or raised pressure?
- Which symptoms should send me to the emergency room instead of your office?
- American Academy of Ophthalmology (2024). Retinal and Ophthalmic Artery Occlusions Preferred Practice Pattern.
- Mac Grory B, Schrag M, Biousse V, et al. Stroke (AHA/ASA Scientific Statement) (2021). Management of Central Retinal Artery Occlusion: A Scientific Statement From the American Heart Association.
- Hagen PT, Scholz DG, Edwards WD. Mayo Clinic Proceedings (1984). Incidence and size of patent foramen ovale during the first 10 decades of life: an autopsy study of 965 normal hearts.
- Messe SR, Gronseth GS, Kent DM, et al. Neurology (American Academy of Neurology) (2020). Practice advisory update summary: Patent foramen ovale and secondary stroke prevention.
- Wieder MS, Blace N, Szlechter MM, Shulman E, Thankenchen J, Mbekeani JN. Arquivos Brasileiros de Oftalmologia (2021). Central retinal artery occlusion associated with patent foramen ovale: a case report and literature review.
- American Academy of Ophthalmology, EyeSmart patient education (2024). What Is a Retinal Artery Occlusion?.
- Turc G, Calvet D, Guerin P, Sroussi M, Chatellier G, Mas JL. Journal of the American Heart Association (2018). Closure, Anticoagulation, or Antiplatelet Therapy for Cryptogenic Stroke With Patent Foramen Ovale: Systematic Review of Randomized Trials, Sequential Meta-Analysis, and New Insights From the CLOSE Study.
- Kent DM, Ruthazer R, Weimar C, et al. Neurology (2013). An index to identify stroke-related vs incidental patent foramen ovale in cryptogenic stroke.
- Chodnicki KD, Pulido JS, Hodge DO, Klaas JP, Chen JJ. Mayo Clinic Proceedings (2019). Stroke Risk Before and After Central Retinal Artery Occlusion in a US Cohort.